Effect of Nicotinic Acid in Prophylaxis of Moderate to Severe Migraine: A Randomized, Double-blind, Placebo-controlled Trial
Condition: Migraine Prophylaxis Interventions: Drug: Nicotinic Acid 500 MG Extended Release Oral Tablet; Drug: Nicotinic Acid 1000 MG Extended Release Oral Tablet; Other: Placebo Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials